Short Wave Is CBD Safe? The FDA Can't Say
Dec 5, 2019
In this insightful discussion, health correspondent Allison Aubrey delves into the booming world of CBD and its potential risks. She highlights the FDA's warnings about drug interactions and reproductive toxicity, raising concerns about its safety. Aubrey contrasts the FDA’s cautious stance with the World Health Organization’s more positive view on CBD. The conversation also covers the regulatory hurdles facing CBD products, emphasizing the need for more research to ensure public safety amidst rising consumer interest.
AI Snips
Chapters
Transcript
Episode notes
CBD Paradox
- CBD's popularity has exploded, with widespread use and ongoing research.
- However, the FDA hasn't yet deemed it safe, except for one epilepsy drug.
FDA's Regulatory Limbo
- The FDA is in a tough spot, playing catch-up with the rapid rise of CBD.
- They are working on regulations but need more data to ensure safety.
Buyer Beware
- Be cautious when buying CBD products off the shelf.
- Quality and contents can vary, so it's a 'buyer beware' situation, similar to supplements.